These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 21658615)

  • 41. Long Non-Coding RNAs Guide the Fine-Tuning of Gene Regulation in B-Cell Development and Malignancy.
    Dahl M; Kristensen LS; Grønbæk K
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30134619
    [TBL] [Abstract][Full Text] [Related]  

  • 42. De novo acute B cell leukemia/lymphoma with t(14;18).
    Stamatoullas A; Buchonnet G; Lepretre S; Lenain P; Lenormand B; Duval C; Callat MP; Gaulard P; Bastard C; Tilly H
    Leukemia; 2000 Nov; 14(11):1960-6. PubMed ID: 11069032
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term survival after histologic transformation of low-grade follicular lymphoma.
    Yuen AR; Kamel OW; Halpern J; Horning SJ
    J Clin Oncol; 1995 Jul; 13(7):1726-33. PubMed ID: 7602362
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clonal heterogeneity assessed by flow cytometry in B-cell lymphomas arising from germinal centers.
    Bellido M; Rubiol E; Ubeda J; Estivill C; Perea G; Rego-Araujo J; Aventín A; Bordes R; Sierra J; Nomdedéu JF
    Am J Clin Pathol; 2002 Jun; 117(6):864-70. PubMed ID: 12047137
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is watch and wait still acceptable for patients with low-grade follicular lymphoma?
    Armitage JO; Longo DL
    Blood; 2016 Jun; 127(23):2804-8. PubMed ID: 26994147
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clonal heterogeneity of lymphoid malignancies correlates with poor prognosis.
    Suguro M; Yoshida N; Umino A; Kato H; Tagawa H; Nakagawa M; Fukuhara N; Karnan S; Takeuchi I; Hocking TD; Arita K; Karube K; Tsuzuki S; Nakamura S; Kinoshita T; Seto M
    Cancer Sci; 2014 Jul; 105(7):897-904. PubMed ID: 24815991
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma.
    Al-Tourah AJ; Gill KK; Chhanabhai M; Hoskins PJ; Klasa RJ; Savage KJ; Sehn LH; Shenkier TN; Gascoyne RD; Connors JM
    J Clin Oncol; 2008 Nov; 26(32):5165-9. PubMed ID: 18838711
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protein kinase CK2 is widely expressed in follicular, Burkitt and diffuse large B-cell lymphomas and propels malignant B-cell growth.
    Pizzi M; Piazza F; Agostinelli C; Fuligni F; Benvenuti P; Mandato E; Casellato A; Rugge M; Semenzato G; Pileri SA
    Oncotarget; 2015 Mar; 6(9):6544-52. PubMed ID: 25788269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of diffuse large B-cell lymphoma from duodenal type follicular lymphoma: a retrospective study of 23 cases.
    Saburi M; Kondo Y; Ogata M; Soga Y; Abe M; Takano K; Kohno K; Nagai T; Nakayama T
    Int J Hematol; 2020 Nov; 112(5):658-665. PubMed ID: 32740764
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations.
    Martinez-Climent JA; Alizadeh AA; Segraves R; Blesa D; Rubio-Moscardo F; Albertson DG; Garcia-Conde J; Dyer MJ; Levy R; Pinkel D; Lossos IS
    Blood; 2003 Apr; 101(8):3109-17. PubMed ID: 12406872
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Aggressive lymphomas: a convenient concept or an anatomo-pathological reality?].
    Pileri SA; Fraternali-Orcioni G; Ascani S; Piccioli M; Poggi S; Piccaluga PP; Leoncini L; Falini B
    Pathologica; 2000 Jun; 92(3):145-61. PubMed ID: 10902425
    [No Abstract]   [Full Text] [Related]  

  • 52. Outpatient fractionated ifosfamide, carboplatin and etoposide as salvage therapy in relapsed and refractory non-Hodgkin's and Hodgkin's lymphoma.
    Hertzberg MS; Crombie C; Benson W; Taper J; Gottlieb D; Bradstock KF
    Ann Oncol; 2006 May; 17 Suppl 4():iv25-30. PubMed ID: 16702181
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019.
    Zelenetz AD; Gordon LI; Abramson JS; Advani RH; Bartlett NL; Caimi PF; Chang JE; Chavez JC; Christian B; Fayad LE; Glenn MJ; Habermann TM; Lee Harris N; Hernandez-Ilizaliturri F; Kaminski MS; Kelsey CR; Khan N; Krivacic S; LaCasce AS; Mehta A; Nademanee A; Rabinovitch R; Reddy N; Reid E; Roberts KB; Smith SD; Snyder ED; Swinnen LJ; Vose JM; Dwyer MA; Sundar H
    J Natl Compr Canc Netw; 2019 Jun; 17(6):650-661. PubMed ID: 31200358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of Histologic Transformation.
    Casulo C
    Hematol Oncol Clin North Am; 2020 Aug; 34(4):785-794. PubMed ID: 32586581
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High Incidence and Clinical Significance of MYC Rearrangements in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
    Schrader AMR; Jansen PM; Vermeer MH; Kleiverda JK; Vermaat JSP; Willemze R
    Am J Surg Pathol; 2018 Nov; 42(11):1488-1494. PubMed ID: 30113335
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas.
    Dogan A; Bagdi E; Munson P; Isaacson PG
    Am J Surg Pathol; 2000 Jun; 24(6):846-52. PubMed ID: 10843287
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early transformation event from follicular lymphoma: our experience of four cases.
    Mehta A; Karki D; Gudapati P
    Pol J Pathol; 2022; 73(2):166-175. PubMed ID: 36200794
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    Musilova K; Devan J; Cerna K; Seda V; Pavlasova G; Sharma S; Oppelt J; Pytlik R; Prochazka V; Prouzova Z; Trbusek M; Zlamalikova L; Liskova K; Kruzova L; Jarosova M; Mareckova A; Kornauth C; Simonitsch-Klupp I; Schiefer AI; Merkel O; Mocikova H; Burda P; Machova Polakova K; Kren L; Mayer J; Zent CS; Trneny M; Evans AG; Janikova A; Mraz M
    Blood; 2018 Nov; 132(22):2389-2400. PubMed ID: 30213873
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of follicularity on autologous transplantation for large-cell non-Hodgkin's lymphoma.
    Vose JM; Bierman PJ; Lynch JC; Weisenburger DD; Kessinger A; Chan WC; Greiner TC; Armitage JO
    J Clin Oncol; 1998 Mar; 16(3):844-9. PubMed ID: 9508164
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dramatic increase in gene mutational burden after transformation of follicular lymphoma into TdT
    Belman JP; Meng W; Wang HY; Li J; Strauser HT; Rosenfeld AM; Zhang Q; Prak ETL; Wasik M
    Cold Spring Harb Mol Case Stud; 2020 Feb; 6(1):. PubMed ID: 31776129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.